Paper Details
- Home
- Paper Details
Late non-neoplastic events in patients with aggressive non-Hodgkin's lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials.
Author: BaarsJoke W, BronDominique, CardePatrice, Kluin-NelemansHanneke C, MeerwaldtJacobus H, MoserElizabeth C, NoordijkEvert M, RaemaekersJohn M M, ThomasJose, TirelliUmberto, van GlabbekeMartine
Original Abstract of the Article :
A significant proportion of patients with aggressive non-Hodgkin's lymphoma (NHL) become long-term survivors. A European Organisation for Research and Treatment of Cancer database of patients with aggressive NHL, consistently treated with doxorubicin-based chemotherapy since 1980, afforded the possi...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.3816/CLM.2005.n.038
データ提供:米国国立医学図書館(NLM)
Long-Term Survival in Aggressive Non-Hodgkin's Lymphoma: A Look at Late Complications
The field of oncology is witnessing remarkable advances in cancer treatment, leading to increased long-term survival rates. This study explores the late non-neoplastic events that can occur in patients who have survived aggressive non-Hodgkin's lymphoma (NHL).
The researchers analyzed data from a European Organisation for Research and Treatment of Cancer (EORTC) database, encompassing patients with aggressive NHL who received doxorubicin-based chemotherapy. Their analysis revealed that a significant proportion of patients with aggressive NHL become long-term survivors, but they may experience late complications, including cardiovascular disease, secondary malignancies, and other health issues.
Late Complications: A Hidden Challenge for Long-Term Survivors
This study highlights the importance of recognizing the potential for late complications in patients who have survived aggressive NHL. It emphasizes the need for long-term follow-up care to monitor for these complications and provide appropriate interventions when necessary. The findings underscore the fact that surviving cancer is not always the end of the journey, but rather the beginning of a new chapter with its own set of challenges.
Navigating Cancer Survivorship: A Long-Term Perspective
Individuals who have survived cancer should engage in ongoing discussions with their healthcare providers to discuss their long-term health risks and develop personalized management plans. This includes regular checkups, screenings, and preventive measures to minimize the risk of late complications. The study underscores the importance of a long-term perspective in cancer survivorship, ensuring that individuals receive the necessary care and support throughout their journey.
Dr.Camel's Conclusion
Cancer treatment, like navigating a vast and unforgiving desert, can leave enduring scars. This study reminds us that the journey of cancer survivorship can be complex, with potential late complications emerging years after initial treatment. By embracing long-term follow-up care and proactive management strategies, we can help individuals navigate the challenges of cancer survivorship and achieve a better quality of life.
Date :
- Date Completed 2006-02-16
- Date Revised 2015-11-19
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.